Assessment of the availability of medicines for patients with mental and behavioral disorders according to the results of a survey of physicians and pharmacists in Ukraine

Authors

DOI:

https://doi.org/10.15587/2519-4852.2023.281222

Keywords:

drug availability, government programs, reimbursement, questionnaire survey of pharmacists and doctors, mental and behavioural disorders

Abstract

The aim: to analyze the results of a questionnaire survey of secondary care physicians and pharmacy pharmacists, participants of the government program "Affordable Medicines" (hereinafter the Program) regarding the assessment of the availability of medicines for patients with mental and behavioural disorders.

Materials and methods: in the research process, legal acts, protocols for the treatment of patients with mental and behavioural disorders, the results of a questionnaire survey of doctors and pharmacists - participants of the Program, scientific publications related to questionnaires of doctors and pharmacists on the topics of generic drug replacement and co-payment were used patients. The research was conducted using the methods of questionnaire survey, systematization and generalization of data.

Research results: 134 doctors and 336 pharmacists from 22 regions of Ukraine took part in the questionnaire survey. According to the results of the survey, it was established that doctors of 11 specialties prescribe medicinal products (pharmaceuticals) for the treatment of patients with mental and behavioural disorders with depressive disorders. Most patients with this disease turn to a secondary care physician without visiting a primary care physician, which negatively affects the availability of medicines for patients, as well as the reliability of statistical indicators of the prevalence and incidence of patients with depressive disorders.

The main problem affecting the availability of drugs for patients with depressive disorders is the lack of drugs in the Program in the presence of the corresponding INN in the Unified Clinical Protocol of primary, secondary (specialized) and tertiary (highly specialized) medical care "Depression", which forces patients to buy drugs on their own cost, and as a result, it leads to a decrease in the availability of medicines for vulnerable sections of the population under the conditions of the war in Ukraine.

As for the issue of generic replacement of drugs according to the results of the questionnaire: 72.4 % of doctors believe that such replacement can only be carried out by a specialist doctor, while 67.9 % of pharmacists confirmed that they carry out generic replacement of prescribed drugs in case of their absence in pharmacies 76.1 % of doctors and 80.6 % of pharmacists support the need for regulatory and legal settlement of the issue of generic drug replacement in order to increase their access and availability for patients. 74.4 % of the surveyed pharmacists confirmed the desire of patients to receive medicines free of charge due to the Program.

Conclusions: The results of the conducted questionnaire survey of doctors and pharmacists showed the importance of the regulatory settlement of issues regarding drug prescriptions under INN, generic substitution of drugs and patient co-payment, as all the listed mechanisms have an impact on increasing the availability of drugs for patients with mental and behavioural disorders. The obtained results also indicate the need to conduct a questionnaire in the future to evaluate the work of the Program and the changes that affect the work of all project participants

Author Biographies

Alla Nemchenko, National University of Pharmacy

Head on Department

Department of Organization and Economics of Pharmacy

Anna Lyadenko, National University of Pharmacy; National Health Service of Ukraine

Postgraduate Student

Department of Organization and Economics of Pharmacy

Lead Specialist

Department of Work with Reimbursement Agreements

Olesia Nemchenko, Limited Liability Company "Panaceya" in Kharkiv

Manager of Pharmacy

Serhii Lebed, State Service for Medicines and Drug Control in the Rivne region

Head of State Service

References

  1. Barsukova, O. (2022). 3-4 million Ukrainians demand liberation through mental disorders after war – Lyashko. Available at: https://life.pravda.com.ua/health/2022/06/8/249013/
  2. Holovni pidsumky realizatsii natsionalnoi prohramy psykhichnoho zdorovia ta psykhosotsialnoi pidtrymky (2022). Available at: https://mon.gov.ua/ua/news/golovni-pidsumki-realizaciyi-nacionalnoyi-programi-psihichnogo-zdorovya-ta-psihosocialnoyi-pidtrimki
  3. Pro vnesennia zminy do Poriadku reimbursatsii likarskykh zasobiv (2022). Postanova Kabinetu Ministriv Ukrainy No. 260. 12.03.2023. Available at: https://www.kmu.gov.ua/npas/pro-vnesennya-zmini-do-poryadku-reimbursaciyi-likarskih-zasobiv-260
  4. Deiaki pytannia realizatsii prohramy derzhavnykh harantii medychnoho obsluhovuvannia naselennia u 2022 rotsi (2021). Postanova Kabinetu Ministriv Ukrainy No. 1140. 29.12.2021. Available at: https://zakon.rada.gov.ua/laws/show/1440-2021-%D0%BF#Text
  5. Pro zatverdzhennia Zmin do deiakykh normatyvno-pravovykh aktiv Ministerstva okhorony zdorovia Ukrainy shchodo zabezpechennia funktsionuvannia sfery okhorony zdorovia u period voiennoho stanu (2022). Nakaz Ministerstva okhorony zdorovia Ukrainy No. 727. 03.05.2022. Available at: https://zakon.rada.gov.ua/laws/show/z0504-22#Text
  6. Pro zatverdzhennia Pravyl vypysuvannia retseptiv na likarski zasoby i medychni vyroby, Poriadku vidpusku likarskykh zasobiv i medychnykh vyrobiv z aptek ta yikhnikh strukturnykh pidrozdiliv, Instruktsii pro poriadok zberihannia, obliku ta znyshchennia retsepturnykh blankiv (2005). Nakaz Ministerstva okhorony zdorovia Ukrainy No. 360. 19.07.2005. Available at: https://zakon.rada.gov.ua/laws/show/z0782-05#Text
  7. Statystyka podanykh deklaratsii pro vybir likaria pervynnoi medychnoi dopomohy. Available at: https://edata.e-health.gov.ua/e-data/dashboard/declar-stats
  8. New pricing models for generic medicines to ensure long-term healthy competitiveness in Europe (2022). Available at: https://www.medicinesforeurope.com/wp-content/uploads/2022/06/New-pricing-models-for-generic-medicines.pdf
  9. Nemchenko, A. S., Lyadenko, A. V. (2022). A study of the impact of patient co-payment on the choice of medication during outpatient treatment under government programs. Scientific and technical progress and optimization of technological processes of the creation of medicinal products. Ternopil, 123–124.
  10. WHO guideline on country pharmaceutical pricing policies (2020). WHO, 70. Available at: https://www.who.int/publications/i/item/9789240011878
  11. Qu, J., Zuo, W., Took, R. L., Schafermeyer, K. W., Lukas, S., Wang, S. et al. (2022). A nationwide survey exploring physicians’ and pharmacists’ knowledge, awareness and perceptions regarding generic medicines in China. BMC Health Services Research, 22 (1). doi: https://doi.org/10.1186/s12913-022-08438-9
  12. Qu, J., Zuo, W., Wang, S., Du, L., Liu, X., Gao, Y. et al. (2021). Knowledge, perceptions and practices of pharmacists regarding generic substitution in China: a cross-sectional study. BMJ Open, 11 (10), e051277. doi: https://doi.org/10.1136/bmjopen-2021-051277
  13. Gebresillassie, B. M. (2018). Evaluating patients’, physicians’ and pharmacists’ perception regarding generic medicines in Gondar, Northwest Ethiopia. Value in Health, 21, S158. doi: https://doi.org/10.1016/j.jval.2018.09.942
  14. Collins, S. (2022). Most physicians unable to estimate patients’ out-of-pocket costs: How pharmacists can help. Available at: https://www.pharmacist.com/Pharmacy-News/most-physicians-unable-to-estimate-patients-out-of-pocket-costs-how-pharmacists-can-help
  15. Dombrowski, S. K., Bacci, J. L., Klatt, P. M., Osborne, M., Castelli, G., Burns, A., Somma McGivney, M. A. (2019). Key factors for sustainable integration of pharmacists in team-based primary care physician practices. Journal of the American Pharmacists Association, 59 (3), 439–448.e1. doi: https://doi.org/10.1016/j.japh.2019.02.005
  16. Chong, C. P., March, G., Clark, A., Gilbert, A., Hassali, M. A., Bahari, M. B. (2011). A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy, 99 (2), 139–148. doi: https://doi.org/10.1016/j.healthpol.2010.08.002
  17. Al Hussaini, M., Alsaffar, N., Abdulraheem, A. (2018). Exploring community pharmacists’ knowledge, perception and experiences towards branded and generic medicines in Kuwait: Highlighting the role of pharmacist. Bulletin of Faculty of Pharmacy, Cairo University, 56 (1), 109–114. doi: https://doi.org/10.1016/j.bfopcu.2018.03.005
  18. Nunes, A. M., Ferreira, D. C., de Matos, A., Julião, R. M. (2020). The Portuguese generic medicines market: What’s next? Health Policy, 124 (4), 397–403. doi: https://doi.org/10.1016/j.healthpol.2020.02.014
  19. Pro vnesennia zminy do Poriadku reimbursatsii likarskykh zasobiv (2022). Postanova Kabinetu Ministriv Ukrainy No. 260. 12.03.2022. Available at: https://www.kmu.gov.ua/npas/pro-vnesennya-zmini-do-poryadku-reimbursaciyi-likarskih-zasobiv-260
  20. Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi) ta tretynnoi (vysokospetsializovanoi) medychnoi dopomohy “Depresiia” (2014). Nakaz Ministerstva okhorony zdorov’ia Ukrainy No. 1003. 2512.2014. Available at: https://www.dec.gov.ua/wp-content/uploads/2019/11/2014_1003_ykpmd_depresiya.pdf
  21. Medicines reimbursement policies in Europe (2022). WHO.
  22. Kaló, Z., Holtorf, A.-P., Alfonso-Cristancho, R., Shen, J., Ágh, T., Inotai, A., Brixner, D. (2015). Need for Multicriteria Evaluation of Generic Drug Policies. Value in Health, 18 (2), 346–351. doi: https://doi.org/10.1016/j.jval.2014.12.012
  23. Sukhovii, O., Khan, O., Doroshenko, O., Shekhar, V. (2022). The Cost of Mental Health in Ukraine: The Review of Privately and Publicly Procured Medicines and Dietary Supplements (2015–2019). Washington: World Bank Group. Available at: https://documents1.worldbank.org/curated/en/099732010062241989/pdf/IDU01a8258cb01c1a0434c0b27a0bc983e705400.pdf
Assessment of the availability of medicines for patients with mental and behavioral disorders according to the results of a survey of physicians and pharmacists in Ukraine

Downloads

Published

2023-06-30

How to Cite

Nemchenko, A., Lyadenko, A., Nemchenko, O., & Lebed, S. . (2023). Assessment of the availability of medicines for patients with mental and behavioral disorders according to the results of a survey of physicians and pharmacists in Ukraine. ScienceRise: Pharmaceutical Science, (3(43), 16–22. https://doi.org/10.15587/2519-4852.2023.281222

Issue

No. 3(43) (2023)

Section

Pharmaceutical Science

License

Copyright (c) 2023 Alla Nemchenko, Anna Lyadenko, Olesia Nemchenko, Serhii Lebed

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.